These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23867305)
1. A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole. Alai MS; Lin WJ Colloids Surf B Biointerfaces; 2013 Nov; 111():453-9. PubMed ID: 23867305 [TBL] [Abstract][Full Text] [Related]
2. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Katara R; Majumdar DK Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100. Jana U; Mohanty AK; Manna PK; Mohanta GP Colloids Surf B Biointerfaces; 2014 Jan; 113():269-75. PubMed ID: 24140793 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Dillen K; Vandervoort J; Van den Mooter G; Ludwig A Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538 [TBL] [Abstract][Full Text] [Related]
6. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery. Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298 [TBL] [Abstract][Full Text] [Related]
7. Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations. Alai M; Lin WJ Int J Nanomedicine; 2015; 10():4029-41. PubMed ID: 26124659 [TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique. Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498 [TBL] [Abstract][Full Text] [Related]
9. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431 [TBL] [Abstract][Full Text] [Related]
11. Composite CD-MOF nanocrystals-containing microspheres for sustained drug delivery. Li H; Lv N; Li X; Liu B; Feng J; Ren X; Guo T; Chen D; Fraser Stoddart J; Gref R; Zhang J Nanoscale; 2017 Jun; 9(22):7454-7463. PubMed ID: 28530283 [TBL] [Abstract][Full Text] [Related]
12. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy. Jones E; Ojewole E; Kalhapure R; Govender T Drug Dev Ind Pharm; 2014 May; 40(5):669-79. PubMed ID: 24576267 [TBL] [Abstract][Full Text] [Related]
14. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles. Misra R; Acharya S; Dilnawaz F; Sahoo SK Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818 [TBL] [Abstract][Full Text] [Related]
15. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles. Li Y; Wong HL; Shuhendler AJ; Rauth AM; Wu XY J Control Release; 2008 May; 128(1):60-70. PubMed ID: 18406489 [TBL] [Abstract][Full Text] [Related]
16. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
17. Optimization and evaluation of bioactive drug-loaded polymeric nanoparticles for drug delivery. Rani R; Dilbaghi N; Dhingra D; Kumar S Int J Biol Macromol; 2015; 78():173-9. PubMed ID: 25881957 [TBL] [Abstract][Full Text] [Related]
18. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery. Gandhi A; Jana S; Sen KK Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259 [TBL] [Abstract][Full Text] [Related]
19. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631 [TBL] [Abstract][Full Text] [Related]
20. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]